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The Cdc25 family of protein phosphatases positively regulates cell division by activating cyclin-dependent
protein kinases (CDKs). In humans and rodents, there are three Cdc25 family members—denoted Cdc25A,
Cdc25B, and Cdc25C—that can be distinguished based on their subcellular compartmentalizations, their
abundances and/or activities throughout the cell cycle, the CDKs that they target for activation, and whether
they are overexpressed in human cancers. In addition, murine forms of Cdc25 exhibit distinct patterns of
expression throughout development and in adult tissues. These properties suggest that individual Cdc25 family
members contribute distinct biological functions in embryonic and adult cell cycles of mammals. Interestingly,
mice with Cdc25C disrupted are healthy, and cells derived from these mice exhibit normal cell cycles and
checkpoint responses. Cdc25B/ mice are also generally normal (although females are sterile), and cells
derived from Cdc25B/ mice have normal cell cycles. Here we report that mice lacking both Cdc25B and
Cdc25C are obtained at the expected Mendelian ratios, indicating that Cdc25B and Cdc25C are not required for
mouse development or mitotic entry. Furthermore, cell cycles, DNA damage responses, and Cdc25A regulation
are normal in cells lacking Cdc25B and Cdc25C. These findings indicate that Cdc25A, or possibly other
phosphatases, is able to functionally compensate for the loss of Cdc25B and Cdc25C in mice.
Cell cycle advancement is regulated, in part, by the dephos-
phorylation and activation of cyclin-dependent protein kinases.
Dephosphorylation and activation of cyclin-dependent protein
kinases are, in turn, catalyzed by the Cdc25 family of protein
phosphatases. Budding and fission yeasts encode a single mem-
ber of this family, whereas the mammalian genome encodes
three family members, designated Cdc25A, Cdc25B, and
Cdc25C (19, 43, 45, 51, 52). The unique functional contribu-
tions made by individual Cdc25 family members to mammalian
cell cycle control and checkpoint control have not yet been
defined.
Experiments performed using mammalian tissue culture
cells have revealed several distinguishing characteristics of
Cdc25 family members. Although cells simultaneously express
all three family members, Cdc25A is nuclear, whereas Cdc25B
and Cdc25C shuttle in and out of the nucleus throughout
interphase, and this activity is dependent on their interactions
with 14-3-3 proteins (9–11, 22, 23, 26, 49). Early cell cycle
studies indicated that the G1-to-S-phase transition was regu-
lated by Cdc25A (5, 26, 31, 55), whereas the G2-to-M-phase
transition was regulated by Cdc25B and Cdc25C. For example,
the microinjection of antibodies specific for either Cdc25B or
Cdc25C arrests cells in G2, suggesting roles for these proteins
at the G2-to-M-phase transition (38, 43). In certain cell types,
Cdc25B has been shown to be an unstable protein that accu-
mulates during the S and G2 phases of the cell cycle. In other
cell lines, the activity of Cdc25B is regulated such that it is most
active during the S and G2 phases of the cell cycle (18, 38, 47).
Furthermore, Cdc25B has a Cdk binding site within its C
terminus that enables the efficient dephosphorylation and ac-
tivation of cyclin A/Cdk2 and cyclin B1/Cdk1 complexes in
vitro (17, 27, 54). Cdc25B has been proposed to regulate cen-
trosomal microtubule nucleation during mitosis (18). Unlike
Cdc25B, the intrinsic phosphatase activity of Cdc25C is low
during the S and G2 phases of the cell cycle. Cdc25C is acti-
vated in mitosis due to phosphorylation by Cdk1/cyclin B1 and
the Polo-like kinase Plk1 (1, 13, 25, 28, 29, 34–36, 38, 50, 60).
Cdk1/cyclin B complexes have been proposed to be the pri-
mary targets for activation by Cdc25C (14, 20, 25, 39, 58).
Microinjection of antibodies against Cdc25A arrests cells in
G1, and the overexpression of Cdc25A accelerates entry of
cells into S phase, implicating a role for Cdc25A in regulating
the G1-to-S-phase transition (5, 26, 31, 55). In addition,
Cdc25A is an E2F target gene, and Cdc25A is required for the
efficient induction of S-phase entry by E2F-1 (59). However,
recent evidence suggests that Cdc25A also plays a role in
regulating the G2-to-M-phase transition (8, 42, 63, 66).
Cdc25A is present and active in all stages of the cell cycle, and
Cdc25A levels actually rise as cells progress from S phase to
mitosis (4, 5, 26, 31, 42, 44, 55). Importantly, Cdc25A has a
docking site for cyclin B1/Cdk1 within its C terminus, which is
masked by 14-3-3 proteins during interphase but exposed dur-
ing mitosis (8). Additional evidence includes the observation
that Cdc25A overexpression accelerates mitotic entry (44) and
the overproduction of phosphatase-dead Cdc25A delays mi-
totic entry (33).
Cdc25A and Cdc25C are targets of negative regulation by
checkpoints that respond to various forms of genotoxic stress.
Checkpoint activation maintains Cdc25C in a 14-3-3 protein-
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bound form, and the overproduction of a mutant of Cdc25C
that cannot bind to 14-3-3 proteins causes a partial bypass of
both the DNA replication and G2 DNA damage checkpoints
(49). Cdc25A stability is regulated as a function of the cell
cycle, and Cdc25A is rapidly degraded in a proteasome-depen-
dent manner in cells exposed to UV light or ionizing radiation
(IR) (4, 6, 12, 16, 21, 24, 30, 41, 42, 44, 66). Chk1 phosphory-
lates Cdc25A to target it for proteolysis during an unperturbed
cell cycle, and the integrity of the Chk1/Cdc25A pathway is
required for cells to delay in the S and G2 phases of the cell
cycle following checkpoint activation (57, 63, 66). In addition,
the overexpression of Cdc25A bypasses the G1 DNA damage
checkpoint and the intra-S-phase checkpoint, resulting in en-
hanced DNA damage and decreased cell survival (42, 44).
In mice, Cdc25A, Cdc25B, and Cdc25C exhibit overlapping
but distinct patterns of expression during development and are
expressed in tissue-specific patterns in adult mice (32, 46, 61,
62). This fact suggests that these genes have distinct biological
functions in embryonic and adult mice. Mice lacking Cdc25C
are viable, develop normally, and do not display any obvious
abnormalities (7). Furthermore, the phosphorylation status of
Cdk1, the timing of entry into mitosis, and the cellular re-
sponses to DNA damage are unperturbed in mouse embryo
fibroblasts (MEFs) lacking Cdc25C (7). Mice with Cdc25B
disrupted are also viable and healthy, although females are
sterile due to a meiotic defect during oogenesis (40). One
explanation for the lack of a cell cycle phenotype in mice with
either Cdc25B or Cdc25C disrupted is compensation by the
other family members and/or other phosphatases. To address
this possibility, we generated mice lacking both Cdc25B and
Cdc25C. Surprisingly, these mice are obtained at the expected
Mendelian ratios and are healthy, demonstrating that Cdc25B
and Cdc25C are dispensable for murine embryonic develop-
ment and for mitotic entry.
MATERIALS AND METHODS
Generation and genotyping of mice with Cdc25B and Cdc25C disrupted. Mice
with both Cdc25B and Cdc25C disrupted were generated by first mating
Cdc25B/ (40) males with Cdc25C/ (7) females. F2 double-heterozygous
littermates of the strain background C57BL/6;129X1SvJ were then interbred to
generate Cdc25B/ Cdc25C/ double knockout mice. PCR analysis was car-
ried out on genomic tail DNA of wild-type (WT) mice, Cdc25B/ knockout
mice, Cdc25C/ knockout mice, and the Cdc25B/ Cdc25C/ double knock-
out mice (BCKO) by using specific primers to confirm the genotypes of the mice.
PCR analysis for Cdc25C was achieved by using a three-primer PCR with primer
5-GGTTCCTTGGATTCATCTGGACC from exon 3, primer 5-CCTCGTG
CTTTACGGTATCGCCG from the neomycin phosphotransferase gene cas-
sette, and primer 5-CCCTACCATGAGTGCAGGGCACC from the intronic
sequence between exons 3 and 4 as described previously (7). Three PCRs were
carried out to identify mice lacking Cdc25B. Primers 5-GCCTGTGAGGCCA
CCTAC and 5-CACTGAACACAACAGACTTC amplify a region in the 3
untranslated region. Primers 5-TGGAGAGGCTATTCGGCTATGAC and 5-
GGCATCGCCATGGGTCACGACGA amplify a region within the neomycin
phosphotransferase gene cassette. Primers 5-GACTGATCGGAGATTACTCT
and 5-TGGAGAGGCTATTCGGCTATGAC amplify a region between exon
10 and the neomycin phosphotransferase gene cassette.
Histology. Tissues were fixed in 10% neutral buffered formalin, rinsed in
phosphate-buffered saline (PBS), and stored in 70% ethanol. Fixed tissues were
embedded in paraffin by using standard procedures. Blocks were sectioned (5
mm) and stained with hematoxylin and eosin.
Animal growth measurements. Heterozygous crosses were used to generate
mice, and postnatal growth curves were obtained by weighing pups at the indi-
cated times by using a Mettler AE 50 scale. Genotyping was performed by PCR
analysis of tail cuttings. All recorded weight averages shown in the growth curves
were compiled from at least 30 mice per genotype per time point.
Northern blotting. RNA was isolated from cells by using the QuickPrep total
RNA extraction kit (Amersham Pharmacia Biotech) according to the manufac-
turer’s suggestions. RNA was resolved on a 1.2% agarose gel and then trans-
ferred to a GeneScreen Plus membrane (NEN). The probes used for screening
mouse tissues and cells include a 440-bp HincII/DraIII restriction fragment of
the murine Cdc25C (mCdc25C) cDNA, a 427-bp XmnI/PvuI restriction fragment
of the mCdc25A cDNA, a 466-bp BglII/SacII restriction fragment of the mCdc25B
cDNA, a 600-bp HindIII/EcoRI restriction fragment of GAPDH, and an1.2-kb
XbaI/HindIII restriction fragment of the neomycin phosphotransferase gene.
Probes were labeled with dCTP (-32P; NEN) by using the Megaprime DNA
labeling system (Amersham). Blots were prehybridized with ExpressHyb solution
(Clontech) containing 100 g of sonicated salmon sperm DNA/ml for 2 to 3 h at
68°C with shaking. Labeled probe was added to 106 cpm/ml, and the blot was
hybridized in ExpressHyb solution for 2 h at 68°C. Blots were washed with 2
SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate)–0.5% sodium dodecyl
sulfate (SDS) at room temperature twice and then washed once with 2 SSC–
0.5% SDS for 15 min with shaking at 50°C.
Generation of mouse embryo fibroblasts. Mouse embryonic fibroblasts were
derived from 13.5-day-old embryos. Following the removal of the head and
organs, each embryo was rinsed with PBS, minced, and digested with trypsin-
EDTA (0.5% trypsin, 0.53 mM EDTA) for 10 min at 37°C, using 1 ml per
embryo. Trypsin was inactivated by the addition of Dulbecco’s modified Eagle’s
media (DMEM; Gibco-BRL) containing 10% fetal bovine serum (FBS), 2 mM
L-glutamine, a 0.1 mM concentration of nonessential amino acids, 140 mM
2-mercaptoethanol, 100 U of penicillin G/ml, and 100 mg of streptomycin/ml.
Cells from single embryos were plated into one 100-mm-diameter tissue culture
dish and incubated at 37°C in a 10% CO2-humidified chamber for 3 days and
then expanded. Each trypsinization and replating represented one passage, and
the split ratio of each passage was 1:3. Early-passage cells (P2 to P4, prior to
crisis) were analyzed for cell cycle progression and for cellular responses to DNA
damage.
Antibodies. Fluorescein isothiocyanate (FITC)-conjugated mouse anti-BrdU
monoclonal antibody was purchased from BD Biosciences. Mouse monoclonal
antibodies specific for Cdc25A were raised against baculovirus-produced gluta-
thione S-transferase (GST)–mCdc25A. Cdk1 was detected with Cdk1-specific
rabbit polyclonal antibody (48). -Catenin mouse monoclonal antibodies were
purchased from BD Transduction Laboratories. Phosphohistone H3 antibodies
were purchased from Upstate Biotechnology (Lake Placid, N.Y.) and then visu-
alized with FITC-conjugated goat anti-rabbit antibody (Jackson ImmunoRe-
search, Inc.). Bound primary antibodies were detected with horseradish peroxi-
dase-conjugated rat anti-rabbit antibody (Zymed) or horseradish peroxidase-
conjugated goat anti-mouse immunoglobulin G (IgG) plus IgM antibody
(Jackson ImmunoResearch, Inc.), and proteins were visualized by chemilumi-
nescence with the ECL reagent (Amersham Pharmacia Biotech).
S-to-G1-phase progression in absence and presence of IR. A total of 106 MEFs
were seeded onto 100-mm-diameter tissue culture dishes 36 h prior to bromode-
oxyuridine (BrdU) labeling. Cells were incubated in 5 ml of culture medium
(DMEM, 10% FBS, 2 mM L-glutamine, a 0.1 mM concentration of nonessential
amino acids, 140 mM 2-mercaptoethanol, 100 U of penicillin G/ml, and 100 mg
of streptomycin/ml) containing 20 mM bromodeoxyuridine (Amersham Pharma-
cia Biotech) at 37°C for 1 h. Medium was removed and replaced with 10 ml of
culture medium, and cells were incubated for the indicated times. Cells were
harvested by trypsinization and collected by centrifugation. After the removal of
the supernatant by aspiration, cells were washed once in PBS and were then
suspended in 0.5 ml of PBS. Cells were fixed by the addition of 5 ml of 70%
ethanol at 4°C in the dark. Pelleted cells were resuspended in 1 ml of 0.4 mg of
pepsin (Sigma Chemical Co.)/ml in 0.1 N HCl and incubated with rocking for 30
min. Nuclear pellets were suspended in 1 ml of 2 N HCl–0.5% NP-40, and
incubated with rocking for 1 h. After neutralization by incubation with 1 ml of 0.1
M sodium borate (pH 8.5) for 5 min, nuclear pellets were suspended in 100 l of
PBS-TB (PBS, 0.5% Tween 20, 1% bovine serum albumin [BSA]) and stained
with 5 l of FITC-conjugated anti-BrdU monoclonal antibody for 1 h in the dark.
Nuclei were washed once with 1 ml of PBS-TB and then incubated with 1 ml of
PBS-TB containing 30 g of propidium iodide (PI)/ml and 250 g of RNase
A/ml for 30 min in the dark. Cells were analyzed for DNA content by flow
cytometry using a FACSCalibur instrument (Becton Dickinson Instruments).
The data were analyzed using CELLQUEST analysis software (Becton Dickin-
son).
G0-to-S-phase progression. A total of 106 MEFs were seeded onto 100-mm-
diameter tissue culture dishes. The following day, cells were incubated in 10 ml
of medium (DMEM, 2 mM L-glutamine, a 0.1 mM concentration of nonessential
amino acids, 100 U of penicillin G/ml, and 100 g of streptomycin/ml) containing
0.1% FBS for 96 h. Cells were reseeded at 106 in medium containing 10% FBS
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and pulsed with 20 M BrdU for 1 h prior to harvest. Harvesting, fixing, staining,
and analysis of cells were carried out as described above.
IR-induced G1-phase checkpoint in MEFs. Cells were plated and serum
starved as for G1 analysis with the following changes. After serum starvation, 2
 106 cells were seeded onto 100-mm-diameter tissue culture dishes and either
mock irradiated or exposed to 20 Gy of IR from a 60Co source. Medium con-
taining 10% FBS and 20 M BrdU was added, and cells were harvested 24 h
later. Cells were fixed, stained, and analyzed by flow cytometry as described
above.
IR-induced G1-phase checkpoint in thymocytes. Eight- to 10-week-old mice
were irradiated with 10 Gy of IR, and injected intraperitoneally with 1 ml of 10
mM BrdU–1 mM fluorodeoxyuridine (Amersham Pharmacia Biotech) at 2 h
postirradiation (3). Mice were sacrificed 1 h after the injection, and thymocytes
were isolated by crushing thymi between glass slides. The prepared thymocytes
were fixed, stained, and analyzed by flow cytometry as outlined above.
IR-induced S-phase checkpoint. MEFs were labeled with 10 nCi of 14C-
thymidine (NEN Life Science Products)/ml for 24 h to control for total DNA
content between samples. Cells were then washed and incubated in culture
medium for 24 h. Cells were either mock irradiated or exposed to 5, 10, or 20 Gy
of IR, incubated for the indicated times, and then pulse labeled with 2.5 Ci of
[3H]thymidine (NEN Life Science Products)/ml for 15 min. Cells were harvested,
washed twice in PBS, and then incubated in 100% methanol for 5 min, followed
by incubation in 10% trichloroacetic acid for 5 min and then 0.3 N NaOH. After
neutralization with HCl, radioactivity was determined by liquid scintillation
counting. The resulting ratios of 3H counts per minute to 14C counts per minute,
corrected for counts per minute that resulted from channel crossover, were
measures of DNA synthesis.
IR-induced G2-phase checkpoint. MEFs were either mock irradiated or ex-
posed to 6 Gy of IR. After 40 min of incubation, 100 ng of nocodazole/ml was
added to trap cells in mitosis, and samples were harvested by trypsinization 1 h
20 min later. A total of 5  105 cells were fixed by the addition of 5 ml of 70%
ethanol at 4°C for as long as 24 h. After fixation, cells were washed twice with
PBS, suspended in 1 ml of 0.25% Triton X-100 in PBS, and incubated at 4°C with
rocking for 15 min. After centrifugation, cell pellets were suspended in 100 l of
PBS containing 1% BSA and 0.75 g of anti-histone H3 antibody and incubated
for 1.5 h at room temperature. Cells were rinsed with PBS containing 1% BSA
and incubated with FITC-conjugated goat anti-rabbit IgG antibody diluted at a
ratio of 1:1,200 in PBS containing 1% BSA. After a 30-min incubation at room
temperature in the dark, cells were washed again and incubated with 500 l of
PBS with 1% BSA containing 30 g of PI/ml and 250 g of RNase A/ml for 30
min, also in the dark. Cells were analyzed by flow cytometry as described above.
Synchronization of MEFs and analysis of Cdk1 phosphorylation. A total of 5
 105 MEFs were seeded onto 100-mm-diameter tissue culture dishes. The
following day, cells were incubated in 10 ml of culture medium containing 0.1%
FBS for 48 h. Cells were then incubated in culture medium containing 15% FBS
and 1 g of aphidicolin/ml (Calbiochem) for 20 h. Cells were released from the
aphidicolin block by being washed twice with 10 ml of PBS and then being
incubated in culture medium containing 15% FBS. Cells were harvested prior to
release (time zero) or at 3, 6, 9, or 12 h after release by trypsinization and
collected by centrifugation. After the removal of the supernatant by aspiration,
cells were washed once in PBS and then were suspended in 0.5 ml of PBS. Cells
were fixed by the addition of 5 ml of 70% ethanol at 4°C. Cells were washed once
with 1 ml of PBS–1% FBS and then incubated with 1 ml of PBS–1% FBS
containing 30 g of PI/ml and 250 g of RNase A/ml for 30 min. Cells were
analyzed for DNA content by flow cytometry using a FACSCalibur instrument
(Becton Dickinson). The data were analyzed by using CELLQUEST analysis
software (Becton Dickinson). For monitoring Cdk1 phosphorylation, cells were
lysed in MCLB {50 mM Tris-HCl, pH 8.0, 2 mM dithiothreitol, 5 mM EDTA,
0.5% Nonidet P-40, 100 mM NaCl, 1 M sodium orthovanadate, phosphatase
inhibitor cocktail [containing 25 M ()-p-bromotetramisole oxalate, 5 mM
cantharidin, and 5 mM microcystin LR; Calbiochem] and protease inhibitor
cocktail [containing 1.04 mM 4-(2-aminoethyl) benzenesulfonyl fluoride
(AEBSF), 15 M pepstatin A, 14 M E-64, 40 M bestatin, 20 M leupeptin,
and 800 nM aprotinin; Sigma] } for 15 min. at 4°C. Cell lysates containing 2 mg
of total cellular protein were incubated with 50 l of packed p13suc1 agarose
(Upstate Biotechnology). After incubation at 4°C for 3 h, precipitates were
washed four times with 1 ml of MCLB. Proteins were resolved by SDS-poly-
acrylamide gel electrophoresis on a 12% SDS gel. Cdk1 phosphorylation status
was monitored by immunoblotting.
Monitoring Cdc25A levels. Asynchronously growing populations of MEFs
were lysed in MCLB. Lysates were resolved by SDS-polyacrylamide gel electro-
phoresis on an 8% SDS gel, transferred to nitrocellulose, and incubated with
mouse ascites specific for mCdc25A. For synchronization studies, 6  105 MEFs
were seeded onto 100-mm-diameter tissue culture dishes and serum starved in
the same manner as for the Cdk1 studies. Cells were harvested prior to release
(time zero) or at 3, 6, 9, or 12 h after release, analyzed for DNA content by flow
cytometry, and processed to monitor Cdc25A levels by Western blotting.
RESULTS AND DISCUSSION
Mice heterozygous for both Cdc25B (40) and Cdc25C (7)
were bred to generate mice lacking both phosphatases. PCR
analysis was carried out on genomic tail DNA by using specific
primers to confirm the genotypes of all mice (Fig. 1A). The
cumulative genotyping of heterozygous crosses resulted in the
expected ratio of each genotype (Table 1). Given that mice
lacking both Cdc25B and Cdc25C were obtained at the ex-
pected Mendelian ratios, this outcome indicates that Cdc25B
and Cdc25C are not required for mouse development or mi-
totic entry. All major organs from BCKO mice were examined
histologically after hematoxylin-eosin staining and appeared
FIG. 1. Genotyping and growth rates of mice with Cdc25B and
Cdc25C disrupted. (A) PCR analysis of mouse tail DNA from WT,
Cdc25B/ (BKO), Cdc25C/ (CKO), and Cdc25B/C/ (BCKO)
mice, using the indicated oligonucleotides. REC, recombinant. (B and
C) WT, Cdc25B/ (BKO), and Cdc25B/C/ (BCKO) male
(B) and female (C) mice were weighed beginning at birth and at
weekly intervals up to 12 weeks. Weights (in grams) represent averages
from at least 30 mice per genotype per time point. Standard deviations
are shown as error bars along the y axis.
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normal (data not shown). Fluorescence-activated cell-sorting
(FACS) analysis using the T-cell markers CD4 and CD8 re-
vealed the expected percentages of single-positive (CD4CD8
and CD4CD8) and double-negative (CD4CD8) T cells
in the peripheral blood of BCKO animals (data not shown).
The weights of individual mice from birth to 3 months of age
were also determined (Fig. 1B and C). As previously reported,
weights of WT and Cdc25C/ mice were indistinguishable
(data not shown) (7). In contrast, Cdc25B/ and BCKO mice
were 8 to 14% and 6 to 10% smaller than their WT littermates,
respectively, beginning at 4 weeks of age. The basis for the
differences in weights is unknown at this time.
Cell cycle progression is normal in cells lacking Cdc25B and
Cdc25C. Fibroblasts derived from wild-type and knockout
mouse embryos were analyzed for their ability to traverse from
G0 into S phase. MEFs were synchronized by serum starvation,
and at various times after the addition of complete media, cells
were incubated with BrdU for 1 h to specifically label cells
that were undergoing DNA replication. Cells were stained for
DNA content with PI and for replicative DNA synthesis with
anti-BrdU antibody and analyzed by flow cytometry. By gating
on BrdU-positive cells, the timing of S-phase entry from G0
could be monitored. As seen in Fig. 2A, similar percentages of
WT and BCKO MEFs were undergoing DNA replication at
each time point tested, indicating that the progression from G0
into S phase is not perturbed in the absence of Cdc25B and
Cdc25C.
Wild-type and BCKO MEFs were also analyzed for their
ability to traverse from S phase through G2 and mitosis and
into G1. Cells were pulse labeled with BrdU to mark S-phase
cells. Cells were harvested at various times after the incuba-
tion and processed for analysis by flow cytometry. By gating
on BrdU-positive cells, cell cycle progression from S phase
through G2/M phase and into the G1 phase of the cell cycle
could be monitored. At the time of the pulse, 17% of WT cells
and 19% of BCKO cells incorporated BrdU. As seen in Fig.
2B, the percentages of BrdU-positive wild-type and BCKO
cells in each phase of the cell cycle were similar. By 3 h, 42.3
and 42.9% of BrdU-positive wild-type and BCKO cells, respec-
tively, had progressed to the G2/M phase of the cell cycle, and
by 6 h, 31.9 and 25.2% of BrdU-positive wild-type and BCKO
cells, respectively, had progressed to the G1 phase of the cell
cycle. These findings indicate that the time required for cells to
progress from S to G1 phases of the cell cycle is unaltered in
murine cells lacking Cdc25B and Cdc25C.
Next, the phosphorylation status of Cdk1 was monitored in
early passage fibroblasts derived from wild-type and BCKO
mouse embryos. Cdk1 is proposed to be a key target of Cdc25B
and Cdc25C in vivo. The phosphorylation of Cdk1 varies as a
function of the cell cycle, and changes in the electrophoretic
mobility of Cdk1 can be used as a specific indicator of Cdk1
phosphorylation status and cell cycle position (2, 56). Wild-
type and BCKO MEFs were arrested in early S phase, by first
being cultured in medium containing low serum and then being
released into complete medium containing aphidicolin. Cells
released from G1/S arrest were then analyzed for DNA content
by flow cytometry and were processed to monitor Cdk1 phos-
phorylation status (Fig. 2C). Wild-type and BCKO cells were
in S phase by 3 h after release, in G2 phase by 6 h after release,
and in the M and G1 phases of the cell cycle by 9 and 12 h after
release, respectively. As seen in Fig. 2C, two electrophoretic
forms of Cdk1 were present in cells arrested at the G1/S border
(lane 1), as well as cells in the S (lane 2) and G2 (lane 3) phases
of the cell cycle. As expected, a loss of the slower electro-
phoretic form of Cdk1 with a concomitant increase in the
fastest electrophoretic form of Cdk1 was observed as cells
entered mitosis (lane 4) and moved into G1 (lane 5). The slight
delay in the dephosphorylation of Cdk1 seen in BCKO cells at
the 9-h time point is a consistent finding. However, the cell
cycle analysis did not reveal significant differences between
wild-type and BCKO cells in their abilities to traverse through
the cell cycle after release from the G1/S-phase arrest. These
findings demonstrate that sufficient quantities of active Cdk1
were generated in BCKO cells to drive cells into mitosis.
Cells lacking Cdc25B and Cdc25C respond normally to ion-
izing radiation. Ionizing radiation activates the IR-induced
DNA damage checkpoint to induce cell cycle delays. This
checkpoint monitors the integrity of the genome and arrests
cells in G1 before DNA replication (termed the IR-induced
G1-phase checkpoint), in S phase (the IR-induced S-phase
checkpoint), or in G2 before mitosis (the IR-induced G2-phase
checkpoint). Checkpoints target the Cdc25A and Cdc25C reg-
ulatory pathways to elicit cell cycle delays following ionizing
radiation exposure (15, 37, 41, 42, 44, 49, 66). To monitor the
IR-induced G1-phase checkpoint in wild-type and BCKO cells,
early passage MEFs were synchronized by serum starvation,
released into complete medium containing BrdU, and imme-
diately mock irradiated or gamma irradiated. Cells harvested
24 h after release were stained for DNA content with PI and
for replicative DNA synthesis with anti-BrdU antibody. As
seen in Fig. 3A, wild-type and BCKO cells showed 57 and 48%
reductions, respectively, in the numbers of S-phase cells rela-
TABLE 1. Actual and expected genotypes of double-heterozygous mating
Parameter (n)
Result (%) for indicated genotypea
W/W W/H W/K H/W H/H H/K K/W K/H K/K
Expected ratio 1 (6.25) 2 (13) 1 (6.25) 2 (13) 4 (26) 2 (13) 1 (6.25) 2 (13) 1 (6.25)
No. of mice
Males (398) 32 (8.04) 47 (11.81) 29 (7.29) 46 (11.56) 93 (23.37) 48 (12.06) 25 (6.28) 53 (13.32) 25 (6.28)
Females (412) 25 (6.07) 68 (16.50) 33 (8.01) 51 (12.38) 95 (23.06) 44 (10.68) 25 (6.07) 40 (9.71) 31 (7.52)
No. of MEFs (236) 19 (8.05) 31 (13.14) 14 (5.93) 24 (10.17) 80 (33.89) 22 (9.32) 7 (2.97) 24 (10.17) 15 (6.36)
Total no. of mice and MEFs (1,046) 76 (7.26) 146 (13.96) 76 (7.27) 121 (11.57) 268 (25.62) 114 (10.89) 57 (5.45) 117 (11.19) 71 (6.79)
a The first genotype represents Cdc25B, and the second genotype represents CDc25C. W, wild type; H, heterozygous; K, knockout.
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tive to the numbers of mock-irradiated control cells at the 24 h
time point. The difference was not statistically significant (P 	
0.2909), indicating that the ability of cells to delay entry into
S phase is intact in cells lacking Cdc25B and Cdc25C.
The IR-induced G1-phase checkpoint in mice was also mon-
itored (3). Animals were mock irradiated or irradiated with 10
Gy of IR and injected with BrdU 2 h postirradiation. At 1 h
postinjection, mice were sacrificed and their thymi were dis-
sected. Thymocytes were analyzed by flow cytometry. As seen
in Fig. 3B, irradiated wild-type and BCKO mice exhibited 48
and 51% reductions, respectively, in the numbers of thymo-
cytes undergoing DNA replication compared with the numbers
of their mock-irradiated counterparts. The difference was not
statistically significant (P 	 0.1638), indicating that the ability
of thymocytes to delay entry into S phase is intact in animals
lacking Cdc25B and Cdc25C.
To determine whether the absence of Cdc25B and Cdc25C
perturbed the IR-induced S-phase checkpoint, [3H]thymidine
incorporation into DNA was monitored 1 h after exposure of
cells to various doses of IR (Fig. 3C). Both wild-type and
BCKO cells had an intact S-phase checkpoint, as indicated by
FIG. 2. Cell cycle analysis of cells lacking Cdc25B and Cdc25C.
(A) WT and BCKO MEFs (passages 4 to 6) were serum starved for
96 h to synchronize cells in G0. After the addition of serum, cells were
incubated with BrdU for 1 h prior to harvest. Cells were stained with
PI and for BrdU and were analyzed by flow cytometry. Each experi-
ment was performed six times in duplicate with independent MEF
strains, and standard deviations are shown as error bars along the y
axis. Differences between WT and BCKO MEFs were not statistically
different at any of the time points (0 h [P 	 0.936], 4 h [P 	 0.7374],
14 h [P	 0.9441], 16 h [P	 0.6278], and 18 h [P	 0.2667]). (B) MEFs
at passages 4 to 6 were pulse labeled with BrdU for 1 h. Cells were
harvested at the indicated times (hours) and stained with PI and for
BrdU. The cellular DNA content of BrdU-positive cells was analyzed
by flow cytometry. Graphs show the averages from six independent
experiments. (C) Early-passage MEFs prepared from wild-type and
BCKO mice were synchronized in early S phase. Cells were harvested
prior to release (time zero) or at various times (hours) after release.
Cdk1 precipitates were resolved on a 12% SDS gel, and Cdk1 was
detected by Western blotting. The arrows indicate two electrophoretic
forms of Cdk1.
FIG. 3. The IR-induced DNA damage checkpoint is intact in
BCKO cells. (A) Early-passage MEFs were serum starved for 96 h.
Arrested cells were mock irradiated or gamma irradiated and then
incubated in BrdU-containing complete medium. Cells were stained
with PI and for BrdU and analyzed by flow cytometry 24 h later. The
percent decreases in S-phase cells following irradiation are indicated.
Differences between WT and BCKO cells were not significant (P 	
0.2909) (B) WT and BCKO mice were mock irradiated (IR) or
gamma irradiated (IR) with 10 Gy of IR and injected intraperitone-
ally with BrdU 2 h later. One hour after the BrdU injection, thymo-
cytes were prepared and analyzed by flow cytometry. The percentages
of S-phase cells are indicated. Standard deviations are shown as error
bars along the y axis. (C) Radioresistant DNA synthesis was assessed
1 h after the exposure of early-passage MEFs to various doses of IR.
Experiments were repeated four times. Differences between WT and
BCKO MEFs were not statistically different at any dose of IR (5 Gy [P
	 0.9035], 10 Gy [P 	 0.2095], and 20 Gy [P 	 0.1333]). Standard
deviations are shown as error bars along the y axis. (D) Early-passage
MEFs were mock irradiated or gamma irradiated and incubated in
nocodazole 40 min later. Cells were costained for DNA content and
histone H3 phosphorylation (p) and were analyzed by flow cytometry
2 h after IR. The percentages of mitotic cells are indicated. The panels
are representative results obtained using WT (n 	 2) and BCKO (n 	
3) MEFs.
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the dose-dependent decrease in [3H]thymidine incorporation
into newly synthesized DNA. Finally, the ability of G2 cells in
cultures of wild-type and BCKO MEFs to delay in G2 within
2 h post-IR was monitored (Fig. 3D). Cells were costained with
PI to assess DNA content and with anti-phosphohistone H3
antibody to identify mitotic cells (64, 65). This experimental
paradigm determines the percentages of G2 cells that move
into mitosis in the absence and presence of double-strand
DNA breaks (64, 65). There was a 96% decrease in the number
of wild-type MEFs that moved from G2 into mitosis following
exposure to IR. A similar decrease in the percentage of mitotic
cells was measured for cells lacking both Cdc25B and Cdc25C,
which is indicative of an intact IR-induced G2-phase check-
point.
Analysis of Cdc25A in MEFs lacking Cdc25B and Cdc25C.
One potential explanation for the lack of an apparent pheno-
type in mice and cells with Cdc25B and Cdc25C disrupted
is compensation by the remaining Cdc25 family member,
Cdc25A. The levels of Cdc25A mRNA in wild-type and BCKO
MEFs were monitored by Northern blotting, and the levels of
Cdc25A protein were monitored by Western blotting (Fig. 4).
As seen in Fig. 4A, the levels of Cdc25A mRNA in BCKO cells
were not detectably altered. The larger RNA species detected
in Northern blots probed for Cdc25B- and Cdc25C-specific
mRNAs are due to the insertion of the neomycin phospho-
transferase gene after homologous recombination. Important-
ly, Cdc25B and Cdc25C proteins are not produced in BCKO
cells (7, 40). A mouse monoclonal antibody raised against re-
combinant GST-mCdc25A was used to examine the levels of
Cdc25A protein in various primary MEF strains. To test the
specificity of the monoclonal antibody, GST-tagged Cdc25A,
Cdc25B, and Cdc25C were blotted with the monoclonal anti-
body and an antibody against GST (Fig. 4B). Only GST-
mCdc25A was recognized by the monoclonal antibody, indi-
cating that it does not cross-react with mCdc25B or mCdc25C.
Differences in total cellular levels of Cdc25A proteins of var-
ious MEF strains were observed, but a consistent pattern of
elevated levels of Cdc25A in BCKO-derived MEFs was not
seen (Fig. 4C). Next, Cdc25A regulation as a function of the
cell cycle was monitored because the abundance of Cdc25A is
regulated in a cell cycle-specific manner by ubiquitin-mediated
proteolysis (4, 6, 12, 26, 30, 41, 42, 44). As seen in Fig. 4D,
Cdc25A levels rose as wild-type and BCKO MEFs progressed
from S phase through G2 and into mitosis and then fell as
cells exited mitosis and entered G1. A substantial increase in
Cdc25A was observed in cells arrested with nocodazole in
mitosis. Thus, the regulation of Cdc25A turnover during the
cell cycle was normal in cells lacking Cdc25B and Cdc25C.
Concluding remarks. Mice lacking two members of the
Cdc25 family of protein phosphatases, Cdc25B and Cdc25C,
are viable, develop normally, and do not display any obvious
abnormalities with the exception that females lacking both
phosphatases are sterile, as are females lacking Cdc25B alone.
Importantly, these findings challenge the paradigm that entry
into mitosis requires Cdc25B and Cdc25C. It is unknown at this
time whether Cdc25A, the remaining member of the Cdc25
family, functionally compensates for the lack of Cdc25B and
Cdc25C or whether other compensatory pathways are in-
volved. Importantly, Cdc25A has a docking site for Cdk1/cyclin
B1 within its C terminus, indicating that Cdc25A is fully capa-
ble of activating Cdk1 to regulate mitotic entry (8). Mice that
can have Cdc25A, Cdc25B, and Cdc25C conditionally deleted
are currently being generated. In this way, Cdc25 phosphatases
can be disrupted individually and in combination to determine
if “adaptation” during development accounts for the lack of
observed phenotype in the BCKO animals, as has been seen in
other germ line knockout models (53).
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